Unified Patent Court (UPC) analytics are now available. Check here

Get Patent Opposition Report for Baxalta

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Baxalta against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2337849Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionSIMIONIMar 12, 2019
EP2634243Improved Process For The Culturing Of CellsDPXMay 30, 2018
EP2261230Protein Purification MethodCHUGAI SEIYAKU KABUSHIKI KAISHAFeb 12, 2018
EP2634242Improved Process For The Culturing Of CellsDPXDec 21, 2017
EP2634250Improved Process For The Culturing Of CellsDPXDec 21, 2017

Explore Baxalta's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3064508Mar 15, 2023Method Of Producing Recombinant High Molecular Weight Vwf In Cell Culture2
EP3521422Oct 6, 2021Substantially Animal Protein-Free Recombinat Furin And Methods For Producing Same2
EP3277718Mar 24, 2021Dosage Regimen For Anti-Mif Antibodies2
EP3121266Apr 22, 2020Oligopeptide-Free Cell Culture Media12
EP2739641Apr 15, 2020Systems And Methods To Increase Protein Yield From Recombinant Manufacturing Processes2
EP3116534May 29, 2019Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders2
EP2652491Nov 29, 2017Eluate Collection Using Conductivity Gradient2
EP2295547Sep 20, 2017Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein Expression2
EP1974014Apr 19, 2017Oligopeptide-Free Cell Culture Media12